SIGGRAPH's Student Volunteer program empowers the next generation of leaders in computer graphics and interactive techniques.
VANCOUVER, BC, July 3, 2025 /PRNewswire/ -- Long recognized as...
Washington D.C, July 02, 2025 (GLOBE NEWSWIRE) -- The time for timid politics is OVER. LFG America stands unwavering and unapologetic behind President Donald Trump’s groundbreaking legislation — the “Big Beautiful Bill” — a no-excuses, no-compromise plan to restore America’s greatness, protect its borders, and unleash economic power for every patriotic American.
DALLAS, July, 1, 2025 /PRNewswire/ -- Populus Financial Group, Inc. (Populus) volunteers taught the JA in a Day program to 739 students at J.O. Davis...
HOFFMAN ESTATES, Ill., June 30, 2025 /PRNewswire/ -- I-CAR®, the collision repair industry's leader in educational programming, related technical services, and industry talent solutions, once...
Community Resource Rally Delivers Essential Aid to Local Families Facing Summer Insecurity
ROGERS, Ark., June 27, 2025 /PRNewswire/ -- With summer in full swing and...
LEIDEN, Netherlands & CAMBRIDGE, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the submission of a Clinical Trial Application (CTA) to the European Medicines Agency (EMA) to initiate a Phase 1 clinical trial of its lead pipeline program AX-0810 targeting NTCP, a liver cell protein that transports bile acids into cells. AX-0810 is an investigational ADAR-mediated RNA editing oligonucleotide (EON) designed to selectively modulate NTCP function by reducing toxic bile acid accumulation in the liver, potentially mitigating inflammation, fibrosis, and progression toward liver failure, which are common in cholestatic diseases.
Organizations providing children with school year essentials through the Back-to-School Brigade®
KATY, Texas, June 26, 2025 /PRNewswire/ -- With back-to-school right around the corner, Academy...
Initiation follows successful IND clearance based on preclinical data package indicating robust increase in fetal hemoglobin with no cytotoxicity
Novel Globin-Switching mechanism derived from...
Survey of over 6,000 people finds the UK is more trusting, friendly and community-minded than some may thinkThree quarters of people trust their neighbours (73%)...
Annual Award Recognizes Those Who Make a Powerful Difference in Their Community
NEW YORK, June 23, 2025 /PRNewswire/ -- EN ESPAÑOL -- AARP is accepting...
Atrogi's breakthrough discovery enables chronic use of next-generation, highly selective β2-agonists for the first time in metabolic diseaseFirst-in-class oral therapy ATR-258 mimics the effects...